The Russian Ministry of Health has chosen PerkinElmer Inc. of Wellesley, Mass., to be the primary supplier of neonatal screening technologies. The ministry has announced an increase in the number of standard screening tests performed on newborns. The new tests include checks for cystic fibrosis, adrenal hyperplasia and galactosemia, in addition to the checks that are already in place for hypothyroidism and phenylketonuria. The products supplied will include reagents, software and instrumentation. Three of the five tests will be performed using the company’s Delfia platform.

In addition, PerkinElmer has announced the acquisition of UK-based Clinical & Analytical Service Solutions Ltd. The latter will be integrated into PerkinElmer’s OneSource service products operation. This line consolidates laboratory service needs, which should increase productivity.